Risk-guided strategy for reducing readmission for Acute Decompensated Heart Failure

Not Applicable

Completed

• Conditions: Heart Failure; Cardiovascular - Other cardiovascular diseases

• Registration Number: ACTRN12618001273279
• Lead Sponsor: Baker Institute for Heart and Diabetes

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-07-27
• Study Completion: 2022-04-30
• Last Update Posted: 18 September 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 122

Inclusion Criteria

1. 18 years of age or older
2. Emergency Department admission with a primary diagnosis of Acute Decompensated Heart Failure confirmed by the treating physicians, in accordance with the HF guidelines.

Exclusion Criteria

1. Unable to provide written informed consent to participate in this study
2. Patients that need palliative care. Discussion with the physician and assessment of palliative care needs.
3. Participating in another clinical research trial where randomisation to study arms would be unacceptable
4. Patients who live in an aged care facility (eg. Nursing Home)
5. Moderate to severe primary mitral or aortic valve disease
6. Concomitant unstable angina, acute myocardial infarction
7. Cardiac device malfunction
8. Endocarditis
9. Patients with Left Ventricular Assistant Device (LVAD)
10. Patients with asymptomatic Left Ventricular (LV) dysfunction
11. Potentially reversible LV dysfunction, such as post-partum, alcoholic cardiomyopathy, hyperthyroidism.
12. Abuse of alcohol or drugs
13. Concomitant terminal non-cardiac illnesses that could influence 12 month prognosis (e.g. advanced malignancy)
14. Inability to acquire interpretable images (identified from baseline echo)
Risk-guided strategy for reducing readmission for Acute Decompensated Heart Failure,
15. In the investigators opinion any other condition that may affect the safety procedures of the study. (patient and personnel)

Study & Design

• Study Type: Interventional
• Study Design: Not specified